These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39050569)

  • 1. Exploring the multifaceted antitumor activity of axitinib in lung carcinoids.
    Oldani M; Cantone MC; Gaudenzi G; Carra S; Dicitore A; Saronni D; Borghi MO; Lombardi A; Caraglia M; Persani L; Vitale G
    Front Endocrinol (Lausanne); 2024; 15():1433707. PubMed ID: 39050569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study.
    Dicitore A; Gaudenzi G; Carra S; Cantone MC; Oldani M; Saronni D; Borghi MO; Grotteschi J; Persani L; Vitale G
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.
    Fiebiger W; Olszewski U; Ulsperger E; Geissler K; Hamilton G
    Clin Transl Oncol; 2011 Jan; 13(1):43-9. PubMed ID: 21239354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M; Schally AV; Pfragner R; Malfertheiner MV; Modlin IM
    Cancer; 2008 Mar; 112(6):1404-14. PubMed ID: 18224665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.
    Pivonello C; Rousaki P; Negri M; Sarnataro M; Napolitano M; Marino FZ; Patalano R; De Martino MC; Sciammarella C; Faggiano A; Rocco G; Franco R; Kaltsas GA; Colao A; Pivonello R
    Endocrine; 2017 Jun; 56(3):603-620. PubMed ID: 27688013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alpha and rapamycin inhibit the growth of carcinoid and medullary thyroid cancer in vitro.
    Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
    Pharmacol Rep; 2014 Aug; 66(4):624-9. PubMed ID: 24948064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axitinib alone or in combination with chemotherapeutic drugs exerts potent antitumor activity against human gastric cancer cells in vitro and in vivo.
    He Q; Gao J; Ge S; Wang T; Li Y; Peng Z; Li Y; Shen L
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1575-83. PubMed ID: 24804814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.
    Somnay Y; Simon K; Harrison AD; Kunnimalaiyaan S; Chen H; Kunnimalaiyaan M
    Anticancer Drugs; 2013 Jan; 24(1):66-72. PubMed ID: 23147412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
    Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
    ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells.
    Spampatti M; Vlotides G; Spöttl G; Maurer J; Göke B; Auernhammer CJ
    World J Gastroenterol; 2014 Aug; 20(29):10038-49. PubMed ID: 25110431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells.
    Morelli MB; Amantini C; Santoni M; Soriani A; Nabissi M; Cardinali C; Santoni A; Santoni G
    Oncotarget; 2015 Nov; 6(34):36245-59. PubMed ID: 26474283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
    Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Lung Carcinoids with Zebrafish Tumor Xenograft.
    Carra S; Gaudenzi G; Dicitore A; Cantone MC; Plebani A; Saronni D; Zappavigna S; Caraglia M; Candeo A; Bassi A; Persani L; Vitale G
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H727 Multicellular Spheroids and Its Resistance to Antitumor Drugs Sunitinib and Axitinib.
    Wang Z; Chen H; Zhou N; Zhang T; Ren P; Chen G
    J Nanosci Nanotechnol; 2018 Dec; 18(12):8078-8084. PubMed ID: 30189922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
    Gilbert JA; Frederick LM; Ames MM
    Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effects of the Ca2+/calmodulin antagonist B859-35 and the Ca(2+)-channel blocker verapamil on human lung cancer cell lines.
    Schüller HM; Orloff M; Reznik GK
    Carcinogenesis; 1991 Dec; 12(12):2301-3. PubMed ID: 1747931
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lee HG; Lim GH; An JH; Park SM; Seo KW; Youn HY
    J Vet Sci; 2024 Jan; 25(1):e1. PubMed ID: 38311316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner.
    Morelli MB; Amantini C; Nabissi M; Cardinali C; Santoni M; Bernardini G; Santoni A; Santoni G
    Oncotarget; 2017 Jan; 8(2):3380-3395. PubMed ID: 27926485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
    Pitt SC; Chen H; Kunnimalaiyaan M
    J Am Coll Surg; 2009 Jul; 209(1):82-8. PubMed ID: 19651067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway.
    Qi X; Zhang S; Chen Z; Wang L; Zhu W; Yin C; Fan J; Wu X; Wang J; Guo C
    Chem Biol Interact; 2022 Jan; 352():109773. PubMed ID: 34902296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.